Sourced from SEC EDGAR

176 Israel-Linked
Investor Records
From US SEC Filings

93 fund issuers and 83 named related persons, pulled directly from SEC EDGAR Form D filings. Built for founders researching the US-Israel funding corridor.

$39
One-time pack, instant CSV download
Latest filings: April 2026
Get the Research Pack
93
Fund issuers
83
Named persons
176
Total records
100%
SEC source-linked

What's Inside

Two clean CSVs, plus a buyer guide and source manifest

๐Ÿข

93 Fund Issuers (CSV)

Israel-linked pooled investment vehicles with city, country, phone, latest filing date, total offering amount, and CIK.

๐Ÿ‘ฅ

83 Related Persons (CSV)

Executive officers and directors named on the underlying Form D filings, mapped back to their funds.

๐Ÿ“Ž

Source URLs + Manifest

Every fund row links back to its SEC primary document. Manifest documents pack scope and field definitions.

Sample Records

Actual rows from the pack

Fund Issuers (4 of 93)

Vintage Secondary Fund VI, L.P. Herzliya Pituach, IL
Glilot Capital Partners IV SPV 2 Herzliya, IL
TPY Capital Partners III SPVQ Tel Aviv-Yafo, IL
LionBird IV L.P. Tel Aviv, IL

Related Persons (4 of 83)

Asaf Horesh
Executive Officer ยท Vintage Secondary Fund VI
Amit Frenkel
Executive Officer ยท Vintage AB Fund, Vintage Secondary Fund VI
Guy Yamen
Executive Officer ยท TPY Capital Partners III
Edward Michael
Executive Officer ยท LionBird IV

Built For

Research and warm-intro prep, not bulk outreach

๐ŸŽฏ

Investor Targeting

Map the active US-Israel fund landscape in one spreadsheet

๐Ÿ“ง

Warm-Intro Prep

Identify named partners before requesting introductions

๐Ÿ“ˆ

Market Intelligence

See offering sizes, filing dates, and fund cadence

๐Ÿ”

Competitive Mapping

Compare which funds are actively raising in your space

What This Pack Is, And Isn't

Set expectations before you buy

โœ“ It is

  • Public-record fund and person rows from US SEC Form D filings
  • Israel-linked pooled investment vehicles (VC, SPV, secondary funds)
  • Source-linked: every fund row points to its SEC primary document
  • A research starting point that saves hours of manual EDGAR digging

โœ— It is not

  • A scraped contact database with personal emails or phone numbers
  • A bulk cold-outreach list (Form D persons are filing-named, not opt-in)
  • A complete map of every Israeli VC (only those with US Form D activity)
  • Fit or quality scored: you decide which funds match your stage and thesis

Common Questions

Where does the data come from?

100% from SEC EDGAR Form D filings, the US public-domain securities filing system. Each fund row in the CSV includes a direct link to the primary SEC document.

Is commercial use allowed?

Yes. The underlying SEC filings are US public-domain. The pack is licensed for commercial research use in US and Israel markets. The buyer guide explains permitted use cases.

Are emails included?

No. Form D filings disclose names, roles, and fund affiliations, not personal emails. The pack is for research and warm-intro prep, not cold-email blasts.

How fresh is the data?

The latest filings in this release date through April 2026. Each row records its own most recent filing date, so you can see filing cadence per fund.

What format is the download?

A ZIP containing two CSVs (funds + persons), a JSON manifest with field definitions, and a buyer guide. Opens in Excel, Google Sheets, Numbers, or any database tool.

What if it's not useful for me?

14-day money-back guarantee, no questions asked. Reply to the Gumroad receipt and we'll refund.

Get Your Research Pack

Instant download after purchase

$39
One-time purchase ยท No subscription

Includes:

  • โœ… 93 Israel-linked fund issuers (CSV)
  • โœ… 83 named related persons (CSV)
  • โœ… SEC primary-document URL for every fund
  • โœ… Filing dates, offering amounts, and fund metadata
  • โœ… JSON manifest with field definitions
  • โœ… Buyer guide with usage notes and guardrails
Buy Now on Gumroad

Secure payment ยท Instant download ยท 14-day money-back guarantee

All data sourced from public SEC EDGAR Form D filings.

Licensed for commercial research use in US and Israel markets.